2014 Health Law & Policy Summer Institute Faculty
Nick Bath is the Senior Health Policy Advisor to Chairman Harkin on the Senate Health Education, Labor, and Pensions (HELP) Committee. Professor Bath started his career on the Hill in 2006 as Counsel and Investigator for the Democratic Policy Committee. From 2007 to 2008, he worked as Senior Counsel on Senator Edward M. Kennedy’s HELP Committee staff. In early 2009, he joined Senator Sheldon Whitehouse’s staff as Legislative Counsel for Health Care and staffed the Senator on the HELP Committee during the health reform debate. In his current position, Professor Bath handles issues related to the coverage title of the Affordable Care Act, including health insurance exchanges, insurance market reforms, and consumer protections, as well as health care quality, HIT, Medicare and Medicaid issues. He received his JD from Harvard Law School. He will be teaching Health Care Economics and the Law.
Mark Botti is co-leader of the Global Antitrust & Competition Practice Group at Squire Sanders, where he advises and represents clients from across many sectors, including healthcare managed care and health information technology, and electronic payment systems. Before joining Squire Sanders, Professor Botti served for 13 years at the US Department of Justice in various litigation and leadership positions within the Antitrust Division. Active in the American Bar Association, Professor Botti is a Vice Chair of the Joint Conduct Committee and was a member of its special task forces on Health Care Reform and Pharmaceutical Reverse Payments. Professor Botti has received numerous distinctions and was listed in The Best Lawyers in America® 2014. He received his JD from Case Western Reserve University School of Law. He will be teachingCurrent Antitrust Topics in the Evolving Healthcare Marketplace. (Click here for fuller bio.)
Susan Crockin is the founder and principal of the Crockin Law & Policy Group, which represents individual clients, agencies, medical and donor programs, and institutions, in and outside of Massachusetts. Professor Crockin has provided legal counsel in over 1,000 adoptions, including co-parent, same-sex, and single parent adoptions; assisted with hundreds of egg donation and gestational carrier arrangements; and provides ongoing and consulting services to private agencies and private and hospital-based medical ART programs throughout the country. She is also a consultant to the Genetics & Public Policy Center in Washington, DC and, in addition to teaching at American University Washington College of Law, holds academic appointments at Georgetown University Law Center and Eastern Virginia Medical School. Professor Crockin received her JD from Northeastern University School of Law. She will be teaching Law & Ethics of Assisted Reproductive Technologies. (Click here for full bio.)
Heidi Gertner is a Senior Attorney in the Office of the Chief Counsel of the US Food and Drug Administration. Prior to joining FDA, Professor Gertner was a Bioethics Fellow in the Department of Clinical Bioethics of the U.S. National Institutes of Health, a Visiting Assistant Professor at Case Western Reserve University's Schools of Law and Medicine, and a Clinical Bioethics Fellow at the Cleveland Clinic Foundation. She has published two law review articles, one of which was cited by the Massachusetts Supreme Court. She has also published articles in The Lancet, Archives of Internal Medicine, Obstetrics & Gynecology, The Journal of Clinical Ethics, and Cambridge Healthcare Ethics Quarterly, among others. Professor Gertner received her JD from Washington University School of Law. She will be teaching Bioethics and the Law. (Click here for fuller bio.)
Daniel Kracov heads the FDA and healthcare practice at Arnold & Porter, LLP, where he assists clients, including start-up companies, trade associations, and large manufacturing companies, in negotiating the challenges relating to the development, approval and marketing of drugs, biologics, and medical devices. Professor Kracov has widely-recognized experience in biomedical product-related public policy matters, including Congressional investigations and FDA-related legislative strategies. He has received numerous distinctions and was listed in The Best Lawyers in America 2014® for FDA law. He graduated from University of Virginia School of Law and will be co-teaching Pharmaceuticals and the Law. (Click here for fuller bio.)
Laura Odwazny is a Senior Attorney with the Office of the General Counsel, U.S. Department of Health and Human Services. Ms. Odwazny’s primary client is the Office for Human Research Protections, which interprets and enforces the HHS regulations that provide protections for human research subjects. Professor Odwazny also currently advises the Presidential Commission for the Study of Bioethical Issues, the HHS Office on Women’s Health, and the HHS Office of Global Affairs. Throughout her 13 years with the Office of the General Counsel, Professor Odwazny has provided legal advice to various other agencies within HHS, including the Office of the Assistant Secretary for Health, the Program Support Center Division of FOIA Services, the Health Resources and Services Administration, the Substance Abuse and Mental Health Administration, and the Office of Research Integrity. Professor Odwazny is a graduate of the University of Chicago and the University of Pittsburgh School of Law, and received a M.A. in Bioethics through the History and Philosophy of Science Department at the University of Pittsburgh. She will be teaching The Law and Ethics of Human Subjects Research.
Matthew Pierce is the Associate Director of the Health Law & Justice Program at American University Washington College of Law. Professor Pierce came to the Washington College of Law from the University of North Carolina Injury Prevention Research Center. His research at UNC focused on evaluating the public health and social justice implications of criminal background screening among employers and universities. He has also researched and written about a variety of other public health law topics, including global and domestic HIV screening policies, the use of zoning laws to prevent obesity; and most recently, the use of prescription monitoring programs to prevent prescription drug overdose. Professor Pierce received his JD from Georgetown and a Masters of Public Health from Johns Hopkins Bloomberg School of Public Health. He will be teaching Epidemiology and the Law. (Click here for fuller bio.)
Tina Rao is the Chief Counsel of Healthcare at Maxim Healthcare Services, Inc., headquartered in Columbia, MD. Professor Rao has substantial experience with corporate compliance, fraud and abuse issues, government investigations and working under government monitor. Previously, she worked as an associate attorney at Epstein Becker and Green, and she has over 10 years of health care experience working for a variety of health care companies and providers. Professor Rao received her JD from Loyola University Chicago law school with a health law certificate, where she served as a health law fellow. Prior to law school, Professor Rao obtained her Masters in Health Administration from the University of North Carolina at Chapel Hill and worked in administration and strategic planning for Novant Health, a North Carolina hospital system. She will be teaching Health Care Fraud and Compliance III: In-House Health Care Practicum.
Michael Ruggiero is Vice President, US Government Affairs and Policy for EMD Serono, the U.S.-based biopharmaceuticals division of Merck KGaA, of Darmstadt, Germany. He leads the function responsible for advising the company on the impact of U.S. policy on business strategy, and shaping the external policy environment to accomplish the company’s business objectives. Mr. Ruggiero sits on the U.S. Country Leadership Team and the Global Government Affairs and Policy Leadership Team. Before joining EMD Serono, Mr. Ruggiero was Vice President, Government Strategy for Astellas Pharma US, Inc., where he led the function responsible for developing policy strategies to accomplish the company’s business objectives; designed and led the first Astellas federal policy and government affairs function; and led cross-functional/regional initiatives to address government policy at a global level. He received his JD from Georgetown University Law Center. He will be co-teaching Pharmaceuticals and the Law.
Asha Scielzo is Special Counsel in the Health Care Group of Pillsbury Winthrop Shaw Pittman, LLP. Her practice consists of advising health systems, hospitals, academic medical centers, physician organizations, pharmaceutical companies and medical device companies in a broad range of health care transactional, compliance and regulatory matters, with specialized expertise in fraud and abuse counseling and transactions (hospital-physician, merger & acquisition, and private equity). Prior to joining Pillsbury, she practiced health care law for over eleven years with Jones Day. Professor Scielzo is an active leader and member of the American Health Lawyers Association (AHLA) and currently serves as the Chair of the Planning Committee for the AHLA Fundamentals of Health Law Conferences. In addition to teaching at American University Washington College of Law, she holds academic appointments at Loyola University Chicago School of Law and Georgetown University Law Center. She received her JD from Georgetown University Law Center. She will be teaching Health Care Fraud and Compliance I: Legal Issues in Health Care Fraud and Abuse and Health Care Fraud and Compliance II: Health Care Corporate Governance and Compliance. (Click here for a fuller bio.)